NCT07596264

Brief Summary

Venous thromboembolism remains a leading cause of preventable mortality in intensive care unit (ICU) patients. Existing risk-stratification tools were developed in general medical populations and lack ICU-specific predictors. This study was to develop and validate an interpretable machine learning (ML) model to predict VTE in ICU patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12,061

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 12, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 19, 2026

Completed
Last Updated

May 19, 2026

Status Verified

January 1, 2022

Enrollment Period

4 years

First QC Date

May 12, 2026

Last Update Submit

May 18, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • validate an interpretable machine learning (ML) model to predict VTE in ICU patients

    the first day after the patients leaf ICU

Interventions

no intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients admitted to ICU were included in the study cohort from January 2022 to October 2025. Inclusion criteria were: (1) age ≥18 years; (2) ICU length of stay ≥48 hours; (3) only the first ICU admission per patient was retained. Exclusion criteria were: (1) VTE diagnosed prior to ICU admission; (2) VTE diagnosed within 24 hours of ICU admission; (3) \>20% missing values in key variables. The final cohort comprised 12,061 patients, of whom 587 (4.9%) developed VTE during ICU hospitalization.

You may qualify if:

  • age ≥18 years;
  • ICU length of stay ≥48 hour
  • the first ICU admission

You may not qualify if:

  • VTE diagnosed prior to ICU admission
  • VTE diagnosed within 24 hours of ICU admission
  • \>20% missing values in key variables

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Tsinghua Changgung Hospital

Beijing, Beijing Municipality, 102218, China

Location

MeSH Terms

Conditions

Venous Thromboembolism

Condition Hierarchy (Ancestors)

ThromboembolismEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
vice president

Study Record Dates

First Submitted

May 12, 2026

First Posted

May 19, 2026

Study Start

January 1, 2022

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

May 19, 2026

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations